Kountourakis Panteleimon, Pavlakis Kitty, Psyrri Amanda, Rontogianni Dimitra, Xiros Nikolaos, Patsouris Efstratios, Pectasides Dimitrios, Economopoulos Theofanis
Second Department of Internal Medicine-Propaedeutic, Athens University Medical School, Attikon university Hospital, Athens, Greece.
BMC Cancer. 2006 Feb 28;6:46. doi: 10.1186/1471-2407-6-46.
Colorectal cancer remains a major cause of cancer mortality in the Western world. A limited number of studies has been conducted in respect of Her-3 and Her-4 expression and their correlation with clinical parameters and prognosis in colorectal carcinomas . In this study we sought to determine the pattern and the prognostic significance of HER-3 and HER-4 in colorectal adenocarcinoma.
We studied HER-3 and HER-4 protein expression in106 paraffin embedded specimens of primary colorectal tumors using immunohistochemistry. The pattern and protein expression levels of HER-3 and HER-4 were correlated with several clinical and pathological parameters.
HER-3 staining displayed membranous and cytoplasmic expression pattern in 18 (17%) and 30 samples (28,3%), respectively. HER-4 membranous and cytoplasmic expression was found in 20 (18,9%) and 32 samples (30,2%), respectively. Specimens regarded as positive for HER-3 cytoplasmic expression were associated with moderate tumor grade (p = 0,032) and older median age (p = 0,010). Specimens regarded as positive for HER-4 membranous protein expression were associated with involved lymphnodes (p = 0,0003). Similar results were obtained when considering Her-3 and Her-4 protein expression irrespective of their cellular localization. There was no correlation between the expression of HER-3 and HER-4 and patients outcome.
HER-4 membranous protein expression was found to predict for lymph nodes positivity in this cohort of patients with colorectal cancer.HER-4 expression status may identify tumors with aggressive biological behavior and increased metastatic potential.
在西方世界,结直肠癌仍然是癌症死亡的主要原因。关于Her-3和Her-4表达及其与结直肠癌临床参数和预后的相关性,所开展的研究数量有限。在本研究中,我们试图确定HER-3和HER-4在结直肠腺癌中的表达模式及其预后意义。
我们采用免疫组织化学方法研究了106例原发性结直肠肿瘤石蜡包埋标本中HER-3和HER-4蛋白的表达情况。HER-3和HER-4的表达模式及蛋白表达水平与多个临床和病理参数相关。
HER-3染色分别在18例(17%)和30例样本(28.3%)中显示出膜性和胞质表达模式。HER-4的膜性和胞质表达分别见于20例(18.9%)和32例样本(30.2%)。被视为HER-3胞质表达阳性的标本与中度肿瘤分级相关(p = 0.032),且年龄中位数较大(p = 0.010)。被视为HER-4膜性蛋白表达阳性的标本与淋巴结受累相关(p = 0.0003)。在不考虑其细胞定位的情况下,观察Her-3和Her-4蛋白表达时也得到了类似结果。HER-�和HER-4的表达与患者预后之间无相关性。
在这组结直肠癌患者中,发现HER-4膜性蛋白表达可预测淋巴结阳性情况。HER-4表达状态可能有助于识别具有侵袭性生物学行为和更高转移潜能的肿瘤。